MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $165 | +139.1% | 40,034 | +239.3% | 0.00% | 0.0% |
| Q4 2022 | $69 | -100.0% | 11,799 | -92.5% | 0.00% | -92.9% |
| Q3 2022 | $1,064,000 | +801.7% | 157,411 | +516.6% | 0.01% | +1300.0% |
| Q2 2022 | $118,000 | -89.3% | 25,529 | -90.8% | 0.00% | -92.9% |
| Q1 2022 | $1,106,000 | +485.2% | 277,089 | +811.1% | 0.01% | +600.0% |
| Q4 2021 | $189,000 | -34.1% | 30,411 | +43.8% | 0.00% | -33.3% |
| Q2 2021 | $287,000 | -67.0% | 21,147 | -35.3% | 0.00% | -62.5% |
| Q4 2020 | $870,000 | +3.9% | 32,704 | -27.3% | 0.01% | -52.9% |
| Q3 2020 | $837,000 | +191.6% | 44,958 | -17.5% | 0.02% | -19.0% |
| Q1 2019 | $287,000 | – | 54,498 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,005,600 | $64,810,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,695,667 | $59,796,000 | 3.39% |
| COMMODORE CAPITAL LP | 429,228 | $6,945,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 357,689 | $5,787,000 | 2.09% |
| Avoro Capital Advisors LLC | 6,800,000 | $110,024,000 | 1.90% |
| Ghost Tree Capital, LLC | 450,000 | $7,281,000 | 1.71% |
| RHO CAPITAL PARTNERS INC | 796,458 | $12,887,000 | 1.24% |
| Rock Springs Capital Management LP | 2,775,127 | $44,902,000 | 0.98% |
| Sio Capital Management, LLC | 157,259 | $2,544,000 | 0.52% |
| Bellevue Group AG | 2,850,010 | $46,113,000 | 0.49% |